Back

MK-7 vs MK-4: Which Form of Vitamin K2 Should You Actually Take?

8 min read

Walk into any supplement store looking for vitamin K2, and you’ll immediately face a choice: MK-4 or MK-7. Both are legitimate forms of menaquinone, both activate the same calcium-regulating proteins, and both have clinical research behind them. But they behave very differently in your body - different half-lives, different dosing requirements, different tissue preferences. Picking the wrong one (or the wrong dose) means you’re leaving benefits on the table.

Quick Comparison

Feature MK-4 MK-7
Primary Mechanism Activates osteocalcin and MGP; serves as mitochondrial electron carrier Activates osteocalcin and MGP; sustained vitamin K recycling
Typical Dosing 1.5-45 mg/day 50-300 mcg/day
Half-Life ~1-2 hours ~3 days (accumulates over weeks)
Best For Bone density at pharmacological doses; brain and mitochondrial support Sustained vitamin K status; cardiovascular protection; general supplementation
Food Sources Butter, egg yolks, liver, chicken, cheese (animal-based) Natto, some fermented cheeses, sauerkraut
Approximate Cost $0.35-1.66/day (depending on dose) $0.15-0.50/day
Common Side Effects None reported at studied doses May interfere with warfarin at 50+ mcg/day
FDA Status Supplement (45 mg approved as drug in Japan) Supplement

What Is MK-4?

MK-4 (menaquinone-4) is the short-chain form of vitamin K2. It has four isoprenoid units in its side chain, making it the most compact of the menaquinones. Unlike MK-7, your body actually produces MK-4 endogenously - the enzyme UBIAD1 converts vitamin K1 (from leafy greens) into MK-4 in various tissues [1]. This conversion happens locally in the brain, kidneys, pancreas, and arterial walls, which tells you something about how fundamental MK-4 is to tissue-level function.

The richest dietary sources are animal-based: grass-fed butter, egg yolks, chicken liver, and dark meat poultry. The catch is that commercial butter from grain-fed cows contains dramatically less MK-4 than its grass-fed counterpart - up to a 50-fold difference depending on the quality of the pasture [2].

Japan has used MK-4 therapeutically for decades. At pharmacological doses of 45 mg/day, menatetrenone (the pharmaceutical name for MK-4) significantly reduced fracture incidence and maintained lumbar bone mineral density in osteoporotic patients over 24 months [3]. Even low-dose supplementation at just 1.5 mg/day improved bone turnover markers and prevented forearm bone loss in postmenopausal Japanese women [4]. MK-4 also functions as a mitochondrial electron carrier - it can shuttle electrons in the respiratory chain similarly to ubiquinone (CoQ10), rescuing ATP production when mitochondrial function is impaired [5].

What Is MK-7?

MK-7 (menaquinone-7) is the long-chain form of vitamin K2, with seven isoprenoid units. Its primary natural source is natto, a Japanese fermented soybean product that contains the highest concentration of K2 of any measured food [2]. Other fermented foods contribute smaller amounts, and bacterial fermentation in your gut produces some MK-7, though the quantity is uncertain.

The defining characteristic of MK-7 is its pharmacokinetics. Where MK-4 disappears from your bloodstream within a couple of hours, MK-7 has a half-life of roughly three days [6]. This means it accumulates during consistent supplementation, reaching steady-state levels 7 to 8 times higher than the initial dose would suggest [7]. At these sustained concentrations, MK-7 induces more complete carboxylation of osteocalcin - the bone protein that requires vitamin K to function - than equivalent supplementation with K1 [7].

MK-7 is also substantially more bioavailable than MK-4, meaning you need far less of it [8]. Where MK-4 requires milligram dosing, MK-7 works in the microgram range. A common supplemental dose of 100-300 mcg of MK-7 is sufficient to meaningfully improve vitamin K status and support both bone and cardiovascular markers [9].

Key Differences Between MK-4 and MK-7

Pharmacokinetics: The Half-Life Gap

This is the single biggest practical difference. MK-4’s half-life of roughly 1-2 hours means blood levels spike and crash quickly [6]. You’d need to dose MK-4 multiple times per day to maintain consistent tissue exposure. MK-7’s multi-day half-life creates stable, accumulating blood levels from a single daily dose [7]. For someone who just wants to take a capsule once a day and not think about it, MK-7 wins on convenience alone.

Dosing: Milligrams vs Micrograms

The dosing gap is enormous. Japanese osteoporosis research uses 45 mg/day of MK-4 - that’s 45,000 micrograms [3]. Meanwhile, meaningful cardiovascular and bone benefits from MK-7 appear at 50-360 mcg/day [10][11]. This 100-fold difference in effective dosing makes MK-7 supplements both simpler to formulate and cheaper per effective dose. Low-dose MK-4 (1.5 mg) has shown bone benefits in Japanese women [4], but that’s still 15 times higher than a typical MK-7 dose.

Tissue Distribution and Unique Roles

MK-4 has biological roles that MK-7 doesn’t clearly replicate. It serves as a mitochondrial electron carrier, directly supporting ATP production in cells with high energy demands [5]. MK-4 also influences brain sulfatide metabolism - sulfatides are critical components of myelin, the insulation around your nerves. Dietary vitamin K status significantly affected brain sulfatide concentrations in animal models, and this effect occurred with both K1 and MK-4 [12]. MK-4 also activates the Gas6 protein in the brain, which controls cell growth, survival, and apoptosis [13].

MK-7, by contrast, excels at systemic, sustained activation of vitamin K-dependent proteins throughout the body. Its long half-life means peripheral tissues like arterial walls get prolonged exposure, which matters for activating matrix GLA protein (MGP) - the key inhibitor of vascular calcification [11].

Cardiovascular Evidence

The cardiovascular data favors MK-7 and other long-chain menaquinones. In the Prospect-EPIC cohort of over 16,000 women, higher intake of vitamin K2 - specifically the longer-chain subtypes MK-7, MK-8, and MK-9 - was inversely associated with coronary heart disease risk, with a hazard ratio of 0.91 per 10 mcg/day increase [14]. Vitamin K1 showed no such association. In hemodialysis patients, MK-7 supplementation dose-dependently reduced inactive MGP (a marker of vascular calcification risk) by 17-46% over 8 weeks [10].

Bone Health Evidence

The bone data is more evenly split. High-dose MK-4 (45 mg/day) has the strongest fracture-prevention evidence from Japanese clinical trials [3]. A meta-analysis of 19 RCTs found vitamin K2 maintained vertebral BMD and reduced fracture incidence in postmenopausal women with osteoporosis [15]. MK-7 has shown improvements in osteocalcin carboxylation - a proxy for bone vitamin K status - but one Norwegian RCT found that 360 mcg/day of MK-7 for 12 months did not reduce bone loss rates in early menopausal women, despite improving biomarker levels [16]. The disconnect between biomarker improvement and actual bone density outcomes is still being worked out.

MK-7 vs MK-4: Which Should You Choose?

If your primary goal is general health maintenance and cardiovascular protection: MK-7 is the better choice. Its long half-life, superior bioavailability, and strong association with reduced heart disease risk make it the most practical daily supplement. A dose of 100-200 mcg covers most people’s needs [8][9].

If you’re managing osteoporosis or have significant bone density concerns: High-dose MK-4 (45 mg/day) has the most direct fracture-prevention evidence, particularly in Japanese populations [3]. This is a therapeutic dose that should be discussed with a physician - it’s a very different proposition than a standard supplement.

If you’re taking high-dose vitamin D3: Vitamin K2 becomes especially important because D3 increases production of vitamin K-dependent proteins, which increases vitamin K demand [17]. MK-7 at 100-200 mcg/day paired with your D3 keeps calcium trafficking running properly.

If you’re concerned about brain health and mitochondrial function: MK-4 has unique roles here that MK-7 doesn’t clearly share [5][12][13]. Even a modest dose of 1-5 mg of MK-4 could complement an MK-7 regimen.

If you’re on warfarin or other blood thinners: Be cautious with MK-7 specifically. Preparations supplying 50 mcg/day or more of MK-7 can interfere with anticoagulant therapy in a clinically relevant way [7]. MK-4’s rapid clearance makes it somewhat less likely to cause sustained INR disruption, but any vitamin K supplementation on anticoagulants requires physician oversight.

Can You Stack MK-4 and MK-7?

Not only can you - many experts argue you should. MK-4 and MK-7 appear to have different tissue distributions at physiological doses, meaning they’re not fully redundant [18]. MK-7 handles the sustained, whole-body vitamin K status that protects your arteries and keeps osteocalcin carboxylated. MK-4 covers the tissue-specific roles in your brain, mitochondria, and locally converted pools.

A practical stacking protocol: 100-200 mcg of MK-7 daily for baseline coverage, plus 1-5 mg of MK-4 if you want the additional tissue-specific benefits [18][19]. Several supplement companies already sell combination products containing K1, MK-4, and MK-7 together - Thorne’s Vitamin K blend, for example, provides 120 mcg K1, 360 mcg MK-4, and 90 mcg MK-7 [20].

MK-4 gets turned over more rapidly than MK-7, and this turnover accelerates when you’re taking other fat-soluble vitamins like A and D [11]. If your stack includes significant vitamin D3 and vitamin A, the argument for including some MK-4 alongside MK-7 gets stronger, since you’re burning through MK-4 faster.

The bottom line: MK-7 is the better standalone choice for most people. But if you want comprehensive vitamin K2 coverage - particularly if you’re optimizing a broader fat-soluble vitamin protocol - combining both forms covers more bases than either one alone.

References

  1. Vos M, et al. - Vitamin K2 is a mitochondrial electron carrier that rescues pink1 deficiency (https://pubmed.ncbi.nlm.nih.gov/22582012/)
  2. Chris Kresser - Vitamin K2: The Missing Nutrient (https://chriskresser.com/vitamin-k2-the-missing-nutrient/)
  3. Shiraki M, et al. - Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis (https://pubmed.ncbi.nlm.nih.gov/10750566/)
  4. Koitaya N, et al. - Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women (https://pubmed.ncbi.nlm.nih.gov/23702931/)
  5. Vos M, et al. - Vitamin K2 is a mitochondrial electron carrier that rescues pink1 deficiency (https://pubmed.ncbi.nlm.nih.gov/22582012/)
  6. SelfHacked - 7 Vitamin K2 Health Benefits + Foods & Deficiency Risks (https://selfhacked.com/blog/top-10-science-based-benefits-vitamin-k2)
  7. Schurgers LJ, et al. - Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7 (https://pubmed.ncbi.nlm.nih.gov/17158229/)
  8. Neurohacker Collective - Vitamin K2 (as Vitaquinone MK-7) (https://www.qualialife.com/formulation/vitamin-k2-as-vitaquinone-mk-7)
  9. Thomas DeLauer - Vitamin K2 Benefits (https://www.youtube.com/watch?v=jcsX5FCWQ2o)
  10. Caluwé L, et al. - Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding study (https://pubmed.ncbi.nlm.nih.gov/24285428/)
  11. Chris Masterjohn - Recording and Transcript of the June 16, 2022 AMA (https://chrismasterjohnphd.com/podcast/2022/06/16/recording-and-transcript-of-the-june-16-2022-ama)
  12. Ferland G - Vitamin K status influences brain sulfatide metabolism in young mice and rats (https://pubmed.ncbi.nlm.nih.gov/8914944/)
  13. Nootropics Expert - Vitamin K2 Myelin & Cell Signaling (https://www.youtube.com/watch?v=FPn0_mH3Uk8)
  14. Gast GC, et al. - A high menaquinone intake reduces the incidence of coronary heart disease (https://pubmed.ncbi.nlm.nih.gov/19179058/)
  15. Huang ZB, et al. - Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials (https://pubmed.ncbi.nlm.nih.gov/25516361/)
  16. Emaus N, et al. - Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial (https://pubmed.ncbi.nlm.nih.gov/19937427/)
  17. Transparent Labs - Vitamin D3 + K2 Benefits: Why They Work Best Together (https://www.transparentlabs.com/blogs/all/d3-k2)
  18. Chris Masterjohn - MK-4 vs MK-7: Vitamin K2 Showdown (https://chrismasterjohnphd.com/qa/2021/01/27/mk-4-vs-mk-7-vitamin-k2-showdown-masterjohn-qa-files-189)
  19. Chris Masterjohn - Mastering Nutrition Episode 18: Fat-Soluble Vitamins (https://chrismasterjohnphd.com/podcast/2016/07/02/the-daily-lipid-podcast-episode-18-you-asked-me-anything-about-fat-soluble-vitamins-facebook-live-062916)
  20. Verywell Fit - The 9 Best Vitamin K Supplements of 2024 (https://www.verywellfit.com/best-vitamin-k-supplements-7187425)

Cart

🎄 SPECIAL ACCESS: EXPIRES SOON!

Join thousands getting stronger this X-mas!

START YOUR NEW YEAR'S RESOLUTION